EARS Quote, Trading Chart, Auris Medical Holding AG
home / stock / ears / ears quote
$3.61 Last:
3.74% Change Percent:
$3.54 Open:
$3.61 Previous Close:
$3.63 High:
$3.5 Low:
340,877 Volume:
06/11/2021 04:42:30 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
EARS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-11 | 3.54 | 3.61 | 3.63 | 3.5 | 340,877 |
| 2021-06-10 | 3.58 | 3.48 | 3.65 | 3.46 | 327,694 |
| 2021-06-09 | 3.6 | 3.55 | 3.75 | 3.55 | 435,287 |
| 2021-06-08 | 3.64 | 3.65 | 3.66 | 3.48 | 552,346 |
| 2021-06-07 | 3.53 | 3.55 | 3.69 | 3.5 | 794,047 |
| 2021-06-04 | 3.72 | 3.47 | 3.72 | 3.41 | 3,200,155 |
| 2021-06-03 | 3.88 | 3.79 | 4.58 | 3.605 | 15,609,784 |
| 2021-06-02 | 3.5 | 3.69 | 3.82 | 3.5 | 513,512 |
| 2021-06-01 | 3.6 | 3.53 | 3.66 | 3.45 | 433,994 |
| 2021-05-31 | 3.45 | 3.59 | 3.77 | 3.45 | 1,414,535 |
| 2021-05-28 | 3.45 | 3.59 | 3.77 | 3.45 | 1,404,120 |
| 2021-05-27 | 3.33 | 3.49 | 3.52 | 3.295 | 547,392 |
| 2021-05-26 | 3.21 | 3.29 | 3.37 | 3.1601 | 429,791 |
| 2021-05-25 | 3.27 | 3.22 | 3.3 | 3.1587 | 266,326 |
| 2021-05-24 | 3.3 | 3.23 | 3.36 | 3.18 | 277,122 |
| 2021-05-21 | 3.38 | 3.3 | 3.54 | 3.26 | 1,244,799 |
| 2021-05-20 | 3.36 | 3.33 | 3.41 | 3.28 | 299,656 |
| 2021-05-19 | 3.2 | 3.36 | 3.37 | 3.15 | 519,640 |
| 2021-05-18 | 3.18 | 3.25 | 3.34 | 3.14 | 604,701 |
| 2021-05-17 | 3.04 | 3.2 | 3.22 | 3.04 | 350,998 |
Auris Medical Holding AG Company Name:
EARS Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc. Trasir’s innovative peptide-based OligoPhore TM platform designed to enable extrahepatic delivery of oligonucleotides Trasir’s founder, Dr. Samuel Wickline, joining leadersh...
-
Hamilton, Bermuda, June 1, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergology, today announced that its affiliate Altamira Medica Ltd. has...
-
Hamilton, Bermuda, May 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced that Chairman and CEO Thomas ...